UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in Balchem Co. (NASDAQ:BCPC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Balchem Co. (NASDAQ:BCPC) by 6.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 83,651 shares of the basic materials company’s stock after purchasing an additional 4,812 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.26% of Balchem worth $14,723,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Balchem by 1.5% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company’s stock worth $604,000 after purchasing an additional 59 shares during the period. Inspire Investing LLC boosted its holdings in shares of Balchem by 2.7% in the 3rd quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company’s stock worth $413,000 after purchasing an additional 62 shares during the period. Hsbc Holdings PLC boosted its holdings in shares of Balchem by 1.5% in the 2nd quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company’s stock worth $757,000 after purchasing an additional 75 shares during the period. Atomi Financial Group Inc. boosted its holdings in shares of Balchem by 6.1% in the 3rd quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company’s stock worth $295,000 after purchasing an additional 96 shares during the period. Finally, Xponance Inc. boosted its holdings in shares of Balchem by 5.2% in the 2nd quarter. Xponance Inc. now owns 2,046 shares of the basic materials company’s stock worth $315,000 after purchasing an additional 102 shares during the period. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Balchem Price Performance

Shares of BCPC stock opened at $177.53 on Friday. Balchem Co. has a 52-week low of $131.10 and a 52-week high of $186.03. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98. The firm has a market capitalization of $5.77 billion, a P/E ratio of 47.72, a P/E/G ratio of 5.32 and a beta of 0.67. The stock has a 50 day moving average price of $174.80 and a 200 day moving average price of $168.23.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright raised their price target on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.